These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38935849)

  • 21. Synthesis of MUC1-derived glycopeptide bearing a novel triazole STn analog.
    Marchiori MF; Bortot LO; Carvalho I; Campo VL
    Carbohydr Res; 2020 Dec; 498():108155. PubMed ID: 33010570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells.
    Leiria Campo V; Riul TB; Oliveira Bortot L; Martins-Teixeira MB; Fiori Marchiori M; Iaccarino E; Ruvo M; Dias-Baruffi M; Carvalho I
    Chembiochem; 2017 Mar; 18(6):527-538. PubMed ID: 28068458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Random glycopeptide bead libraries for seromic biomarker discovery.
    Kracun SK; Cló E; Clausen H; Levery SB; Jensen KJ; Blixt O
    J Proteome Res; 2010 Dec; 9(12):6705-14. PubMed ID: 20886906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
    Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and immunological evaluation of the unnatural β-linked mucin-1 Thomsen-Friedenreich conjugate.
    Wu X; McFall-Boegeman H; Rashidijahanabad Z; Liu K; Pett C; Yu J; Schorlemer M; Ramadan S; Behren S; Westerlind U; Huang X
    Org Biomol Chem; 2021 Mar; 19(11):2448-2455. PubMed ID: 33645601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope.
    Singh J; Her C; Supekar N; Boons GJ; Krishnan VV; Brooks CL
    J Pept Sci; 2020 Jan; 26(1):e3229. PubMed ID: 31729101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray.
    Pedersen JW; Blixt O; Bennett EP; Tarp MA; Dar I; Mandel U; Poulsen SS; Pedersen AE; Rasmussen S; Jess P; Clausen H; Wandall HH
    Int J Cancer; 2011 Apr; 128(8):1860-71. PubMed ID: 21344374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Breast Tumor Growth after Immunization with a Tumor-Restricted MUC1 Glycopeptide Conjugated to Tetanus Toxoid.
    Stergiou N; Gaidzik N; Heimes AS; Dietzen S; Besenius P; Jäkel J; Brenner W; Schmidt M; Kunz H; Schmitt E
    Cancer Immunol Res; 2019 Jan; 7(1):113-122. PubMed ID: 30413430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.
    Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ
    Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.
    Sarkar S; Salyer AC; Wall KA; Sucheck SJ
    Bioconjug Chem; 2013 Mar; 24(3):363-75. PubMed ID: 23444835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.
    Wilkinson BL; Day S; Chapman R; Perrier S; Apostolopoulos V; Payne RJ
    Chemistry; 2012 Dec; 18(51):16540-8. PubMed ID: 23090901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
    Seko A; Ohkura T; Ideo H; Yamashita K
    Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
    Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
    J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic Cancer.
    Palitzsch B; Gaidzik N; Stergiou N; Stahn S; Hartmann S; Gerlitzki B; Teusch N; Flemming P; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2016 Feb; 55(8):2894-8. PubMed ID: 26800384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
    Carotenuto A; D'Ursi AM; Mulinacci B; Paolini I; Lolli F; Papini AM; Novellino E; Rovero P
    J Med Chem; 2006 Aug; 49(17):5072-9. PubMed ID: 16913697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
    Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
    Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
    Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
    Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines.
    Liu Y; Wang Z; Yu F; Li M; Zhu H; Wang K; Meng M; Zhao W
    Int J Nanomedicine; 2021; 16():403-420. PubMed ID: 33469292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide.
    Trabbic KR; Whalen K; Abarca-Heideman K; Xia L; Temme JS; Edmondson EF; Gildersleeve JC; Barchi JJ
    Sci Rep; 2019 Apr; 9(1):5662. PubMed ID: 30952968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.